Heidelberg Materials AG (LON:0MG2)

Verve Therapeutics Statistics

Total Valuation

LON:0MG2 has a market cap or net worth of GBP 29.81 billion. The enterprise value is 37.04 billion.

Market Cap	29.81B
Enterprise Value	37.04B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	May 16, 2025

Share Statistics

Current Share Class	177.72M
Shares Outstanding	n/a
Shares Change (YoY)	-2.22%
Shares Change (QoQ)	-1.49%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	127.01M

Valuation Ratios

The trailing PE ratio is 18.37 and the forward PE ratio is 14.39.

PE Ratio	18.37
Forward PE	14.39
PS Ratio	1.61
PB Ratio	1.91
P/TBV Ratio	4.36
P/FCF Ratio	17.67
P/OCF Ratio	10.57
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.38, with an EV/FCF ratio of 21.95.

EV / Earnings	22.82
EV / Sales	1.96
EV / EBITDA	9.38
EV / EBIT	13.26
EV / FCF	21.95

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.48.

Current Ratio	1.15
Quick Ratio	0.69
Debt / Equity	0.48
Debt / EBITDA	2.19
Debt / FCF	4.40
Interest Coverage	10.74

Financial Efficiency

Return on equity (ROE) is 11.00% and return on invested capital (ROIC) is 6.87%.

Return on Equity (ROE)	11.00%
Return on Assets (ROA)	5.30%
Return on Invested Capital (ROIC)	6.87%
Return on Capital Employed (ROCE)	10.70%
Revenue Per Employee	366,267
Profits Per Employee	32,022
Employee Count	50,692
Asset Turnover	0.62
Inventory Turnover	2.83

Taxes

In the past 12 months, LON:0MG2 has paid 646.07 million in taxes.

Income Tax	646.07M
Effective Tax Rate	27.17%

Stock Price Statistics

The stock price has increased by +99.82% in the last 52 weeks. The beta is 1.15, so LON:0MG2's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	+99.82%
50-Day Moving Average	189.47
200-Day Moving Average	153.20
Relative Strength Index (RSI)	46.33
Average Volume (20 Days)	71,432

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0MG2 had revenue of GBP 18.57 billion and earned 1.62 billion in profits. Earnings per share was 9.08.

Revenue	18.57B
Gross Profit	11.90B
Operating Income	2.54B
Pretax Income	2.38B
Net Income	1.62B
EBITDA	3.39B
EBIT	2.54B
Earnings Per Share (EPS)	9.08

Balance Sheet

The company has 1.14 billion in cash and 7.42 billion in debt, giving a net cash position of -6.28 billion.

Cash & Cash Equivalents	1.14B
Total Debt	7.42B
Net Cash	-6.28B
Net Cash Per Share	n/a
Equity (Book Value)	15.58B
Book Value Per Share	82.81
Working Capital	878.71M

Cash Flow

In the last 12 months, operating cash flow was 2.82 billion and capital expenditures -1.13 billion, giving a free cash flow of 1.69 billion.

Operating Cash Flow	2.82B
Capital Expenditures	-1.13B
Free Cash Flow	1.69B
FCF Per Share	n/a

Margins

Gross margin is 64.07%, with operating and profit margins of 13.70% and 8.74%.

Gross Margin	64.07%
Operating Margin	13.70%
Pretax Margin	12.81%
Profit Margin	8.74%
EBITDA Margin	18.28%
EBIT Margin	13.70%
FCF Margin	9.09%

Dividends & Yields

This stock pays an annual dividend of 2.77, which amounts to a dividend yield of 1.41%.

Dividend Per Share	2.77
Dividend Yield	1.41%
Dividend Growth (YoY)	8.05%
Years of Dividend Growth	4
Payout Ratio	31.09%
Buyback Yield	2.22%
Shareholder Yield	3.63%
Earnings Yield	5.44%
FCF Yield	5.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7